Medical
Arrhythmia Research Technology (AMEX: HRT)
http://www.arthrt.com
Phone: 978-345-5000
Arrhythmia Research Technology, Inc. (ART) is engaged in the development of medical software, which analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias. ARTÌs product consists of signal-averaging electrocardiographic (SAECG) software named the PREDICTOR series. Its SAECG product is used in a National Institutes for Health (NIH) funded investigation into Risk Stratification in MADIT II Type Patients.
InfuSystems Holdings, Inc.(AMEX: INFU)
http://www.infusystem.com
Phone: 248-291-1210
Infusystem Holdings, Inc., is a provider of ambulatory infusion pump management services for oncologists in the United States. Ambulatory infusion pumps are small, lightweight electronic pumps designed to be worn by patients, and which allow patients the freedom to move about while receiving chemotherapy treatments. Its core service is to provide oncology offices, infusion clinics and hospital out-patient chemotherapy clinics with ambulatory infusion pumps in addition to related supplies.
MISONIX, Inc. (NASDAQ: MSON)
http://www.misonix.com
Phone: 631-694-9555
MISONIX, Inc. designs, manufactures, develops and markets minimally invasive ultrasonic medical device products. These products include the BoneScalpel cutting system which is used among other things for surgical procedures of the spine, the SonaStar Surgical Aspirator which is used to emulsify and remove soft and hard tumors, the SonicOne Wound Cleansing and Debridement and fibrin deposits while sparing viable cells, and the AutoSonix ultrasound cutting and coagulating system.
TearLab Corporation (NASDAQ: TEAR)
http://www.tearlab.com
Phone: 858-455-6006
TearLab Corp., formerly OccuLogix, Inc., is an in-vitro diagnostic company based in San Diego, California. The Company is commercializing a tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its product measures tear film osmolarity for the diagnosis of Dry Eye Disease, or DED. Its subsidiary is TearLab, Inc.
Uroplasty, Inc. (NASDAQ: UPI)
http://www.uroplasty.com
Phone: 952-426-6140
Uroplasty, Inc. is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Companyís primary focus is on two products: the Urgent PC system and Macroplastique. The Urgent PC system is a United States Food and Drug Administration (FDA)-approved minimally invasive, office-based neuromodulation therapy for the treatment of urinary urgency, urinary frequency and urge incontinence that are symptoms often associated with overactive bladder (OAB).
Recent Comments